IL-17 antagonistic antibodies fpr treating cancer
Details for Australian Patent Application No. 2007235199 (hide)
International Classifications
Event Publications
7 August 2008 PCT application entered the National Phase
PCT publication WO2007/117749 Priority application(s): WO2007/117749
23 September 2010 Application Accepted
Published as AU-B-2007235199
28 October 2010 Corrigenda
Applications Accepted - Name Index Under the name Novartis AG, Application No. 2007235199, under INID (54) correct the title to read IL-17 antagonistic antibodies for treating cancer
20 January 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser